�Թϲ�����

Teladoc Health Inc.’s shares caught a little chill after Amazon.com Inc. announced the start of a virtual healthcare service for its workers in the Seattle area. Shares fell for a second day after the e-commerce company’s launch of “Amazon Care,” with Wednesday’s decline the most intraday in a month. The pilot program is an online primary care clinic that also offers in-home nurse visits and prescription delivery. (Sircar, 9/25)

Walmart’s Sam’s Club is teaming up with several health care companies to offer discounts on everyday care its customers might delay or skip because of the cost. Starting early October, Sam’s Club members in Michigan, Pennsylvania and North Carolina, will be able to buy one of four bundles of health care services ranging in annual fees from $50 for individuals to $240 for a family of up to six members. The pilot program could potentially be rolled out to members in all the states, says Lori Flees, senior vice president of Sam’s Club Health and Wellness. (D'Innocenzio and Murphy, 9/26)

The nation’s largest consumer electronics chain, known for selling TV sets, cellphones and laptops, is looking to health care as a big source of its future growth. Best Buy Co. said Wednesday that in five years it hopes to provide 5 million seniors with health monitoring services, which can range from sensors placed throughout a home to a pendant worn around the neck. It currently provides the service to 1 million. It’s part of the chain’s deeper push into the $3.5 trillion U.S. health care market and essential to its goal of reaching $50 billion in annual revenue by 2025. (D'Innocenzio, 9/25)

Business is booming for the ambulatory surgery industry, but traditional device makers are having a hard time tapping into it, according to a new report from Bain & Company. In the desperate race to cut costs out of healthcare, ambulatory surgery centers have emerged as a promising solution. ASCs performed more than half of all outpatient surgeries in 2017, up from 32% in 2005, the report found. Orthopedic, spine and cardio procedure volumes are projected to see the most growth through the mid-2020s. (Bannow, 9/25)

Consumer genetics giant 23andMe announced Thursday that it would move deeper into the business of clinical trial recruitment, partnering with a fast-growing startup to help match its customers with nearby study sites based on their diseases, demographics, and DNA. The Silicon Valley company has for months been quietly making inroads into clinical trial recruitment by emailing customers who’ve opted in with recommendations about studies that might be appropriate for them. It has recruited for studies, both interventional and observational, in disease areas including Alzheimer’s, Parkinson’s, attention-deficit hyperactivity disorder, eczema, and liver disease, a spokesperson for the company confirmed. (Robbins, 9/26)